| Date | Time | Source | Headline | Symbol | Company |
| 02/14/2017 | 6:02AM | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) | NASDAQ:SGNT | Sagent Pharmaceuticals, Inc. |
| 09/09/2016 | 8:06AM | Edgar (US Regulatory) | Termination of Registration of a Class of Security Under Section 12(b) (15-12b) | NASDAQ:SGNT | Sagent Pharmaceuticals, Inc. |
| 09/06/2016 | 5:02AM | Edgar (US Regulatory) | Notice of Effectiveness (effect) | NASDAQ:SGNT | Sagent Pharmaceuticals, Inc. |
| 09/02/2016 | 2:30PM | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) | NASDAQ:SGNT | Sagent Pharmaceuticals, Inc. |
| 09/01/2016 | 5:03PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:SGNT | Sagent Pharmaceuticals, Inc. |
| 09/01/2016 | 5:02PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:SGNT | Sagent Pharmaceuticals, Inc. |
| 08/31/2016 | 5:28PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:SGNT | Sagent Pharmaceuticals, Inc. |
| 08/31/2016 | 5:28PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:SGNT | Sagent Pharmaceuticals, Inc. |
| 08/31/2016 | 5:28PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:SGNT | Sagent Pharmaceuticals, Inc. |
| 08/31/2016 | 5:28PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:SGNT | Sagent Pharmaceuticals, Inc. |
| 08/31/2016 | 5:28PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:SGNT | Sagent Pharmaceuticals, Inc. |
| 08/31/2016 | 5:28PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:SGNT | Sagent Pharmaceuticals, Inc. |
| 08/31/2016 | 5:28PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:SGNT | Sagent Pharmaceuticals, Inc. |
| 08/31/2016 | 5:28PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:SGNT | Sagent Pharmaceuticals, Inc. |
| 08/31/2016 | 5:28PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:SGNT | Sagent Pharmaceuticals, Inc. |
| 08/31/2016 | 5:28PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:SGNT | Sagent Pharmaceuticals, Inc. |
| 08/31/2016 | 5:28PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:SGNT | Sagent Pharmaceuticals, Inc. |
| 08/31/2016 | 5:27PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:SGNT | Sagent Pharmaceuticals, Inc. |
| 08/30/2016 | 1:56PM | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:SGNT | Sagent Pharmaceuticals, Inc. |
| 08/30/2016 | 1:51PM | Edgar (US Regulatory) | Post-effective Amendment to Registration Statement (pos Am) | NASDAQ:SGNT | Sagent Pharmaceuticals, Inc. |
| 08/29/2016 | 3:18PM | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:SGNT | Sagent Pharmaceuticals, Inc. |
| 08/29/2016 | 3:12PM | Edgar (US Regulatory) | Amended Statement of Ownership: Solicitation (sc 14d9/a) | NASDAQ:SGNT | Sagent Pharmaceuticals, Inc. |
| 08/29/2016 | 12:17PM | Edgar (US Regulatory) | (25-NSE) | NASDAQ:SGNT | Sagent Pharmaceuticals, Inc. |
| 08/29/2016 | 6:58AM | Business Wire | Nichi-Iko Pharmaceutical Co., Ltd. Announces Results of Tender Offer to Purchase All of the Outstanding Shares of Common Stoc... | NASDAQ:SGNT | Sagent Pharmaceuticals, Inc. |
| 08/29/2016 | 5:17AM | Edgar (US Regulatory) | Amended Tender Offer Statement by Third Party (sc To-t/a) | NASDAQ:SGNT | Sagent Pharmaceuticals, Inc. |
| 08/24/2016 | 8:23AM | Edgar (US Regulatory) | Amended Tender Offer Statement by Third Party (sc To-t/a) | NASDAQ:SGNT | Sagent Pharmaceuticals, Inc. |
| 08/22/2016 | 4:51PM | PR Newswire (US) | Chemical Financial Set to Join S&P MidCap 400; Supervalu, Shoe Carnival and Eagle Pharmaceuticals to Join S&P SmallCap 600 | NASDAQ:SGNT | Sagent Pharmaceuticals, Inc. |
| 08/22/2016 | 5:10AM | Edgar (US Regulatory) | Amended Tender Offer Statement by Third Party (sc To-t/a) | NASDAQ:SGNT | Sagent Pharmaceuticals, Inc. |
| 08/18/2016 | 3:56PM | Edgar (US Regulatory) | Amended Tender Offer Statement by Third Party (sc To-t/a) | NASDAQ:SGNT | Sagent Pharmaceuticals, Inc. |
| 08/18/2016 | 3:39PM | Edgar (US Regulatory) | Amended Statement of Ownership: Solicitation (sc 14d9/a) | NASDAQ:SGNT | Sagent Pharmaceuticals, Inc. |